GERON ($GERN) posted quarterly earnings results for Q4 2025 on Wednesday, February 25th. The company reported earnings of -$0.03 per share, beating estimates of -$0.03 by $0.00. The company also reported revenue of $48,020,000, missing estimates of $51,428,910 by $-3,408,910.
You can see Quiver Quantitative's $GERN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GERON Insider Trading Activity
GERON insiders have traded $GERN stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $GERN stock by insiders over the last 6 months:
- MICHELLE ROBERTSON (EVP, CHIEF FINANCIAL OFFICER) sold 9,855 shares for an estimated $19,118
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GERON Hedge Fund Activity
We have seen 89 institutional investors add shares of GERON stock to their portfolio, and 154 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. removed 9,606,217 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $13,160,517
- DEEP TRACK CAPITAL, LP removed 8,585,251 shares (-20.9%) from their portfolio in Q4 2025, for an estimated $11,332,531
- MILLENNIUM MANAGEMENT LLC removed 6,764,113 shares (-59.5%) from their portfolio in Q4 2025, for an estimated $8,928,629
- STEMPOINT CAPITAL LP removed 6,649,244 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $9,109,464
- SOLEUS CAPITAL MANAGEMENT, L.P. added 6,000,000 shares (+34.7%) to their portfolio in Q4 2025, for an estimated $7,920,000
- VESTAL POINT CAPITAL, LP removed 5,905,000 shares (-34.3%) from their portfolio in Q4 2025, for an estimated $7,794,600
- CITADEL ADVISORS LLC removed 5,779,282 shares (-36.8%) from their portfolio in Q4 2025, for an estimated $7,628,652
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
